We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Https://www.londonstockexchange.com/news-article/OCTP/patent-applications/16282243
Like HEMO need some well overdue positive news
Very nice read up 👍
Even Hemo on there, which I've got 🤗
Could be a great year for boths
Https://total-market-solutions.com/2023/12/10-companies-to-follow-in-2024/
Not much time for plenty of news before Christmas. Maybe tomorrow?
Have been promised “plenty” of news by Xmas so would expect to hear something very soon . Am in other shares where no news / comms is absolutely killing the SP
Been no real action here for months. Must be due to waiting for funding/plan next stage.
.
Would be nice to get back over a penny for Xmas 🎅
Small top up from me
Yes at last, sp been suppressed although markets have been in free-fall in the last month or so. Incredible buying opportunity at this ridiculous level.
OCTP will have progressed towards their phase 2 trials so expecting RNS confirming this together with hopefully further news on their other products. They are still fully funded till 2 qtr next year. Any positive news will establish a good finance deal taking them through near production late into 2024.
Finally ticked up after a week.
Haven’t been able to buy any shares of a meaningful amount all day with out going to negotiated trade and still no change in ask price.
Negotiated to buy so may tick up soon.
Looks like we had a few new people join the telegram group yesterday, with some chunky buys showing across the day.
Would be nice to see the share return to the 1.35 region, before we get either some industry breaking or financial update news.
The share price has dwindled. Agree must be down to funding. However I would hope OCTP would have not just made the appointment if they thought they were not going to get funding moving forward to stage 2. I expect we as shareholders will take a hit in the next funding as in these early development companies we always seem to.
It doesn't pay to have one's head in the sand; I think this is a company with great potential but it does seem to be running headlong into a brick wall, and I think it is perfectly reasonable to question the strategy of prioritising the long term when in six months there will be no company without a fund raise. Shareholders should be clamouring for management to deal with this issue, since not doing so will inevitably lead to an outcome far more dilutive for existing shareholders. Look at the share price - it is drifting lower as the money runs out and thus the cost for existing shareholders is growing.
However, if you wish to ignore the funding wall and praise management for accelerating towards it, please feel free.
I will remain cautious until there is some prospect of funding through to the company being cash flow positive. Until that point it is absolutely impossible to know whether there is any value in the company's shares, since we do not know what the cost of the funding will be.
considering you never ever post its seems like you know a lot. why don't you trott off and spread your negativity elsewhere as the people that actually are invested and care/have knowledge defo not going to listen to the ****3 you talking
At a time when the company needs a fund raise yesterday, adding to the cost base appears like an...interesting choice...
Today 07:00
RNS Number : 2956T
Oxford Cannabinoid Tech.Holdings
14 November 2023
Oxford Cannabinoid Technologies Holdings plc
("OCTP" or the "Company")
Directorate Appointment
Oxford Cannabinoid Technologies Holdings plc (LSE: OCTP), the pharmaceutical company developing prescription cannabinoid medicines, announces the following Board appointment.
Reflecting his exceptional experience and valued contribution to the progress of OCTP, the Company is pleased to announce the appointment of Dr Tim Corn, Chief Medical Officer ("CMO"), as an executive director, effective immediately. As announced on 8 June 2023, Dr Corn joined OCTP as CMO to oversee the Company's clinical research and development activities as well as to provide expert medical guidance and advice to the team. Since joining, the Company has successfully completed its first Phase I clinical trial, a single ascending dose study of its lead compound OCT461201.
Dr Corn, formerly Chief Medical Officer International at Jazz Pharmaceuticals plc, has played a key role in the successful conclusion of more than twenty regulatory approvals in the US and Europe and is the author of more than forty scientific publications. He was elected Fellow of both the Faculty of Pharmaceutical Medicine and the Royal College of Psychiatrists.
They have cash runway to Q1 next year, so they need to have completed a fund raise before then to avoid insolvency. To continue trading currently, the Board must have confidence that they can complete a fund raise, or they are committing a criminal offence of trading whilst insolvent. The Board should never have left it so late to complete a fund raise, but having done so they will have to undertake a deeply dilutive issue, as any new investor will regard the current business as essentially worthless, and will be weighing up buying the IP out of insolvency vs underwriting a placing and open offer, which would incur costs not necessary in a purchase from an insolvency. Whether the licence with Canopy Growth would survive an insolvency might make this moot - if it falls away then a potential buyer could just negotiate with Canopy Growth, and not worry about OCTP at all.
I'm thinking there will be some good news running up to them raising funds which i think is early next year if memory serves me correct although i've kinda forgotten about this investment lately.
Some order best be being put together.. up 7% on a few hundred quids worth of trades 🤔
Been no action for weeks other than a slow decline in price. Phase 1 completed then standstill. Hope lots going on behind the scenes.
Never seen so many trades daily for a few pence in a share.
I look to see if its any action, to see a page of minnows